Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.
Journal: Molecular carcinogenesis
Published: April 23, 2024
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Journal: Investigational new drugs
Published: December 07, 2022
Cell Squeeze: driving more effective CD8 T-cell activation through cytosolic antigen delivery.
Journal: Immuno-oncology technology
Published: August 31, 2022
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice.
Journal: Frontiers in immunology
Published: August 09, 2022
Engineered RBCs Encapsulating Antigen Induce Multi-Modal Antigen-Specific Tolerance and Protect Against Type 1 Diabetes.
Journal: Frontiers in immunology
Published: February 04, 2022
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 06, 2021
Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 02, 2018
Microneedle-based device for the one-step painless collection of capillary blood samples.
Journal: Nature biomedical engineering
Published: August 17, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026